Literature DB >> 11782019

Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.

Alexandra M Livingstone1, Marina Kuhn.   

Abstract

Immunization with cells expressing endogenous antigens can stimulate long-lived CD8(+) T cell memory. In many cases, the response is also stimulated by host antigen-presenting cells (APC) that have processed antigen from internalized apoptotic cells or cell fragments. This study investigated whether immunization with peptide-pulsed dendritic cells (DC) could prime long-lasting, peptide-specific CD8(+) T cell immunity in the absence of cross-priming by host APC. C57BL / 6 female mice immunized with syngeneic male splenic DC pulsed with the H-2K(b)-restricted ovalbumin peptide OVA(257 - 264) made memory CD8(+) CD44(high) T cell responses to OVA(257 - 264) and the male antigen HY more than 1 year after immunization. Establishment and maintenance of peptide-specific CD8(+) T cell memory did not require antibody or B cells. Immunization of H-2(bxd) mice with OVA(257 - 264)-pulsed minor-incompatible H-2(b) or H-2(d) DC demonstrated that CD8(+) T cells were primed exclusively by the injected cells, and not by peptide transferred to host APC, even though there was very effective cross-priming for CD8(+) T cell responses to the minor antigens expressed by the DC. Thus peptide-pulsed DC can prime long-lasting CD8(+) memory responses without any requirement for cross-priming by other APC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782019     DOI: 10.1002/1521-4141(200201)32:1<281::AID-IMMU281>3.0.CO;2-P

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Unravelling the mechanisms of help for CD8+ T cell responses.

Authors:  Alexandra M Livingstone; Elizabeth B Wilson; Fernando Ontiveros; Jyh-Chiang E Wang
Journal:  Immunol Res       Date:  2009-02-18       Impact factor: 2.829

2.  Polyinosinic-cytidylic acid as an adjuvant on natural killer- and dendritic cell-mediated antitumor activities.

Authors:  Yu-Kun Huang; Zhi Zheng; Fu Qiu
Journal:  Tumour Biol       Date:  2013-02-22

3.  Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.

Authors:  Fernando Ontiveros; Elizabeth B Wilson; Alexandra M Livingstone
Journal:  Immunology       Date:  2011-01-24       Impact factor: 7.397

4.  Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response.

Authors:  Martin Prlic; Gabriela Hernandez-Hoyos; Michael J Bevan
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

5.  Different maturation cocktails provide dendritic cells with different chemoattractive properties.

Authors:  Chiara Massa; Carolin Thomas; Ena Wang; Francesco Marincola; Barbara Seliger
Journal:  J Transl Med       Date:  2015-06-03       Impact factor: 5.531

6.  CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma.

Authors:  Hakimeh Ebrahimi-Nik; William L Corwin; Tatiana Shcheglova; Alok Das Mohapatra; Ion I Mandoiu; Pramod K Srivastava
Journal:  Cancer Immunol Immunother       Date:  2018-07-20       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.